Publication: 2985

Publication: 2985

Ibrutinib alone or in combination with rituximab produces superior progression free survival compared with bendamustine plus rituximab in untreated older patients with chronic lymphocytic leukemia: Results of Alliance A041202

DOI

URL

Google Scholar

Citation:: Blood vol 132 (Suppl 1) 6

Meeting Instance:: ASH 2018
Year:: 2018
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 3028

Program:: OGC
Primary Committee:: Leukemia
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, U10CA180820, U10CA180790, U10CA180888

Corr. Author:
Authors:: Jennifer A. Woyach Amy S. Ruppert Nyla Heerema Weiqiang Zhao Allison M Booth Wei Ding Nancy Bartlett Danielle M Brander Paul M Barr Kerry A Rogers Sameer Parikh Steven Coutre Arti Hurria Gerard Lozanski Sreenivasa Nattam Richard A. Larson Harry Erba Mark Litzow Carolyn Owen James Atkins Jeremy Abramson Richard M. Stone Sumithra Mandrekar John C. Byrd

Networks:: LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NC010, LAPS-OH007, NC002, NY167, OH070

Study: Alliance-A041202
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: